SATURDAY, May 30, 2020 (HealthDay News) -- Headed to the beach or park for a little fresh air? Don't forget your sun protection, the American Academy of Dermatology (AAD) advises. Skin cancer is the most common cancer in the United States, affecting one in five Americans, but many don't protect themselves from harmful UV rays. Sixty percent of respondents to an AAD survey said they had had such a bad sunburn their clothes were uncomfortable, and 43% hurt too much to sleep. "Sunburns are highly preventable, but each year, one in three U.S. adults gets sunburned," said AAD president Dr. Bruce Thiers. "As dermatologists, we know that unprotected exposure to the sun's harmful UV rays is a major risk factor for skin cancer," he said in an academy news release. "It only takes a few...

FRIDAY, May 29, 2020 (HealthDay News) -- Women with cancerous cells in their milk ducts -- also known as DCIS -- are at a high risk for developing fatal breast cancer, British researchers report. DCIS is short for ductal carcinoma in situ, an early form of breast cancer. With stepped-up breast screening, it has become an increasingly common diagnosis. Though it's not immediately life-threatening, DCIS more than doubles a woman's risk of developing an invasive breast cancer and dying from it, according to a large study of tens of thousands of women in the United Kingdom. And the increased risk can persist 20 years or more -- longer than previously thought. But surveillance of women after a DCIS diagnosis typically focuses on the first few years, according to lead author Gurdeep...

FRIDAY, May 29, 2020 (HealthDay News) -- Marijuana has long been linked to a host of mental health risks, but the potent strains sold today may amplify those dangers, new research suggests. "We know that people who use cannabis are more likely to report mental health problems than those who don't use cannabis, but we don't fully understand how recent increases in the strength and potency of cannabis affects this," explained study author Lindsey Hines, a senior research associate from the University of Bristol Medical School in England. For the study, researchers examined data from a large, ongoing British study and focused on more than 1,000 people who were born in the early 1990s and reported recent pot use when they were 24. The scientists were also able to track which participants...

FRIDAY, May 29, 2020 (HealthDay News) -- For men with advanced prostate cancer, a new hormone therapy pill works better than standard injections -- and carries a much lower risk of heart attack or stroke, a clinical trial has found. The drug, called relugolix, is not yet approved by the U.S. Food and Drug Administration. If it gets the green light, however, it would be "game-changing," said Dr. Neal Shore, lead researcher on the trial. Hormone therapy has long been a standard treatment for advanced prostate cancer -- including cases where the tumor has spread beyond the prostate gland or recurred after treatment with surgery or radiation. The goal is to suppress androgen hormones, including testosterone, because they fuel the growth of prostate tumors. Right now, that's usually...